Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,079
Total Claims
$1.9M
Drug Cost
427
Beneficiaries
$4,491
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+218%
Cost per patient vs peers
$4,491 vs $1,411 avg
+72%
Brand preference vs peers
18.2% vs 10.6% avg
Brand vs Generic
Brand: 4,916 claims · $1.4M
Generic: 22,045 claims · $500K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 945 | $269K |
| Sitagliptin Phosphate | 475 | $130K |
| Macitentan | 16 | $95K |
| Dulaglutide | 133 | $82K |
| Sacubitril/Valsartan | 171 | $57K |
| Rivaroxaban | 162 | $44K |
| Empagliflozin | 137 | $40K |
| Dolutegravir Sodium | 35 | $37K |
| Insulin Glargine,hum.Rec.Anlog | 319 | $36K |
| Insulin Detemir | 153 | $32K |
| Sodium Zirconium Cyclosilicate | 33 | $32K |
| Sevelamer Carbonate | 134 | $26K |
| Brimonidine Tartrate/Timolol | 145 | $26K |
| Latanoprost | 536 | $23K |
| Fluticasone/Umeclidin/Vilanter | 34 | $23K |
Prescribing Profile
Patient Profile
82
Avg Age
62%
Female
2.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data